3,4-methylenedioxyamphetamine has been researched along with n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.90) | 18.7374 |
| 1990's | 12 (38.71) | 18.2507 |
| 2000's | 13 (41.94) | 29.6817 |
| 2010's | 2 (6.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, AJ; Jacob, P; Nichols, DE; Oberlender, RA; Shulgin, AT | 1 |
| Cozzi, NV; Marona-Lewicka, D; Monte, AP; Nichols, DE | 1 |
| Kurrasch, D; Marona-Lewicka, D; Nichols, DE; Parker, MA; Shulgin, AT | 1 |
| Clare, BW | 1 |
| Callaway, CW; Geyer, MA | 1 |
| Callaway, CW; Geyer, MA; Gold, LH; Johnson, MP; Nichols, DE | 1 |
| Nichols, DE; Oberlender, R | 1 |
| Johnson, MP; Nichols, DE | 1 |
| Dimpfel, W; Nichols, DE; Spüler, M | 1 |
| Nichols, DE; Steele, TD; Yim, GK | 1 |
| Marona-Lewicka, D; Nichols, DE | 2 |
| Marona-Lewicka, D; Nichols, DE; Rhee, GS; Sprague, JE | 1 |
| Kronstrand, R | 1 |
| Brownfield, MS; Levy, AD; Li, Q; Murakami, I; Nichols, DE; Stall, S; Van de Kar, LD | 1 |
| Sadeghipour, F; Veuthey, JL | 1 |
| Dulawa, SC; Geyer, MA; Hen, R; Scearce-Levie, KA | 1 |
| Carter, N; Forrest, AR; Milroy, CM; Rutty, GN | 1 |
| Kurosu, A; Kuroyanagi, K; Matsushima, K; Nagai, T; Nihei, H; Saotome, A; Suzuki, A; Tokudome, S | 1 |
| Kovar, KA; Mayerhofer, A; Meyer, A; Schmidt, WJ | 1 |
| Kovar, KA; Lebsanft, HB; Mayerhofer, A; Schmidt, WJ | 1 |
| Concheiro, M; Cruz, A; de Castro, A; López-Rivadulla, M; Quintela, O | 1 |
| Corkery, J; Deluca, P; Ghodse, AH; Oyefeso, A; Schifano, F | 1 |
| Goda, Y; Kawamura, M; Kikura-Hanajiri, R; Kodama, Y; Saisho, K | 1 |
| Chèze, M; Deveaux, M; Lhermitte, M; Martin, C; Pépin, G | 1 |
| Ishii, H; Nakagawa, Y; Ogata, A; Suzuki, T; Tayama, S | 1 |
| Kamata, HT; Kamata, T; Katagi, M; Miki, A; Mori, Y; Shima, N; Tsuchihashi, H; Zaitsu, K | 1 |
| Maurer, HH; Meyer, MR; Peters, FT | 2 |
| Awad, T; Belal, T; Clark, CR; DeRuiter, J; Maher, HM | 1 |
| Covaci, A; Erratico, C; Kinyua, J; Lai, FY; Mueller, JF; van Nuijs, AL | 1 |
31 other study(ies) available for 3,4-methylenedioxyamphetamine and n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine
| Article | Year |
|---|---|
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.
Topics: Adult; Animals; Butylamines; Dioxoles; Discrimination Learning; Female; Generalization, Stimulus; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psychotropic Drugs; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Benzofurans; Brain; Discrimination Learning; Dopamine; Indenes; Male; Molecular Structure; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrahydronaphthalenes | 1993 |
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA).
Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents; Behavior, Animal; Brain; Dioxoles; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Serotonin Agents; Synaptosomes | 1998 |
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory | 1998 |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Fluoxetine; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1992 |
Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Biogenic Amines; Brain Chemistry; Dose-Response Relationship, Drug; Exploratory Behavior; Fluoxetine; Male; Motor Activity; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1991 |
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Hallucinogens; Indans; Learning; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Stereoisomerism | 1990 |
Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Biogenic Monoamines; Brain Chemistry; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Norepinephrine; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1989 |
Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Central Nervous System Stimulants; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electroencephalography; Evoked Potentials; Hallucinogens; Injections, Intraperitoneal; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred F344; Telemetry | 1989 |
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Biological Transport; Corpus Striatum; Depression, Chemical; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dopamine; Hippocampus; Hypothalamus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism; Synaptosomes | 1987 |
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Stereoisomerism | 1994 |
Psychostimulant-like effects of p-fluoroamphetamine in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Behavior, Animal; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Calibration; Gas Chromatography-Mass Spectrometry; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Reference Standards; Serotonin; Substance-Related Disorders; Sweden | 1996 |
Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Fluoxetine; Indans; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vasopressins | 1996 |
Sensitive and selective determination of methylenedioxylated amphetamines by high-performance liquid chromatography with fluorimetric detection.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, High Pressure Liquid; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Substance Abuse Detection; Tablets | 1997 |
Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents, Second-Generation; Citalopram; Conditioning, Operant; Discrimination, Psychological; Fluoxetine; Indans; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 1998 |
Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Mice; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Oxadiazoles; Piperazines; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Reflex, Startle; Serotonin; Serotonin Agents; Serotonin Antagonists | 2000 |
Deaths associated with MBDB misuse.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Autopsy; Cause of Death; Dancing; Female; Humans; Male; Substance-Related Disorders; Suicide; United Kingdom | 2000 |
Enantiomer analysis of a new street drug, 3,4-methylenedioxy-N-methyl-butanamine, in rat urine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Chromatography, High Pressure Liquid; Illicit Drugs; Male; Rats; Rats, Wistar; Stereoisomerism; Substance Abuse Detection | 2002 |
Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Animals; Catalepsy; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2002 |
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Animals; Apomorphine; Behavior, Animal; Citalopram; Dopamine; Fenclonine; Functional Laterality; Hallucinogens; Male; Medial Forebrain Bundle; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotation; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2003 |
Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection.
Topics: 3,4-Methylenedioxyamphetamine; Chromatography, High Pressure Liquid; Forensic Medicine; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Saliva; Spectrometry, Fluorescence; Substance Abuse Detection | 2005 |
Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine-Related Disorders; Cause of Death; Crime; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug and Narcotic Control; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Statistics as Topic; United Kingdom | 2006 |
The disposition into hair of new designer drugs; methylone, MBDB and methcathinone.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Gas Chromatography-Mass Spectrometry; Hair; Methamphetamine; Models, Animal; Propiophenones; Rats | 2007 |
Simultaneous analysis of six amphetamines and analogues in hair, blood and urine by LC-ESI-MS/MS. Application to the determination of MDMA after low ecstasy intake.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Amphetamines; Chromatography, Liquid; Female; Forensic Toxicology; Hair; Hallucinogens; Humans; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection | 2007 |
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes.
Topics: 3,4-Methylenedioxyamphetamine; Adenosine Triphosphate; Animals; Cell Death; DNA Damage; Hallucinogens; Hepatocytes; Male; Methamphetamine; Mitochondria, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Phosphorylation; Rats; Rats, Inbred F344; Time Factors | 2009 |
Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Hydrolysis; Methylation | 2009 |
Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers.
Topics: 3,4-Methylenedioxyamphetamine; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dealkylation; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Oxidation-Reduction; Oxidoreductases, N-Demethylating; Stereoisomerism; Substrate Specificity | 2009 |
Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers.
Topics: 3,4-Methylenedioxyamphetamine; Antibodies, Monoclonal; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; In Vitro Techniques; Kinetics; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Stereoisomerism | 2009 |
GC-MS studies on side chain regioisomers related to substituted methylenedioxyphenethylamines: MDEA, MDMMA, and MBDB.
Topics: 3,4-Methylenedioxyamphetamine; Gas Chromatography-Mass Spectrometry; Illicit Drugs; Molecular Conformation; Molecular Weight; Stereoisomerism | 2010 |
Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amines; Amphetamines; Benzodioxoles; Benzofurans; Butylamines; Catalysis; Chromatography, Liquid; Cytochrome P-450 Enzyme System; Cytosol; Designer Drugs; Dose-Response Relationship, Drug; Female; Humans; Likelihood Functions; Liver; Male; Mass Spectrometry; Methamphetamine; Microsomes, Liver; Models, Chemical; Phenethylamines; Propylamines; Reproducibility of Results; Substance Abuse Detection; Wastewater; Water Purification | 2015 |